Fee Request For Malpractice Suit 'Stunning,' Pharma Biz Says
Pharma giant Lupin is asking the Delaware Chancery Court to reject a bid by managers of a company it bought in 2017 to be reimbursed roughly $275,000 in legal fees for...To view the full article, register now.
Already a subscriber? Click here to view full article